18. Hitzenberger G., Radhofer-Welte S., Takacs F. et al. Pharma-
cokinetics of lornoxicam in man.//Postgrad.Med.J. — 1990. —
66. — Suppl.4. — pp.22-6.
19. Johnson A.D., Seideman P., Day R.D. Advers drug interaction
with NSAID. Recognition. Management and avoidance.//
Drug.Saf. — 1993. — 8. — p.99.
20. Jorg Berg, Thomas Christoph, Margot Widerna and Angelica
Bodente. Jsoenzyme-Specific Cyclooxygenase Inhibitors: A
Hole Cell Assay System Using the Human. Erythrolukemic
Cell line MELi and the Human Monocytic Cell Line Mono
Mac 6.//Journal of Pharmacological and Toxicological Meth-
ods. — 1997. — 37. — pp.179-186.
21. Levy M. Pharmacokinetics of metamizol metabolites.//In:
Burne K. (Ed). 100 years of pyrazolone drugs.-Basel.-
Birkhauser Verlag. — 1986. — pp.199-204.
22. McCormack K. Nonsteroidal antiinflammatory drugs and the
dissociation between their antiinflammatory and analgesic ef-
fects.//Drugs. — 1994. — 47. — Suppl.5. — pp.28-45.
23. McCormack K. The spinal actions of nonsteroidal
antiinflammatory drugs and the dissociation between their
antiinflammatory and analgesic effects.//Drugs. — 1994. — 47.
— Suppl. — 5. — pp.28-45.
24. McCormack K. Nonsteroidal antiinfiammatory drugs and
spinal nociceptive processing.//Pain. — 1994. — 59. — pp.6-43.
25. Norholt S.E., Sindet-Petersen S., Larsen U. et al. Pain con-
trol after dental surgery; a double-blind, randomised trial of
lornoxicam versus morphine.//Pain. — 1996. — 67. —
pp.335-343.
26. Paulus H.E. FDA Arthritis Advisory Commitee meeting: post-
marketing surveillance of nonsteroidal antiinflammattory
drugs.//Arthritis Rheum. — 1985. — 28. — pp.1168-9.
27. Proceedings of round table on lornoxicam.//Viena. — 1998. —
May.
28. Pruss T.P., Stroissnig H., Radhofer-Welte S. et al. Overview of
the pharmacological properties, pharmacokinetics and animal
safety assessment of lornoxicam.//Postgrad.Med.J. — 1990. —
66. — Suppl.4. — pp.18-21.
29. Rosenov D.E., Albrechtsen M., Stoike D. A comparison of
patient-controlled analgesia with lornoxicam versus morphine
in patients undergoing lumbar disk surgery.//Anesthesia &
Analgesia. — 1998. — 86. — pp.1045-50.
30. Schnitzer T.J. Non-NSAID pharmacologic treatment options
for the management of chronic pain.//Am.J.Med. — 1998. —
105. — pp.45-52.
31. Vane J.R., Bottling P.M. Overview: Mechanisms of action of
antiinflammatory drugs.//In: Vane J.R., Bottling J., Bottling
R. (Es). Improved Non-Steroid Antiinflammatory Drugs.
COX-2 Enzyme Ingibitors.-Kluwer Academic Publishers. —
William Harvey Press. — 1996. — pp.1-27.
32. Ventura A., Vizzardi M., Berlusconi M. Pilot study on anal-
gesic activity of lornoxicam.//Gazzetta Medica Italiana. —
1991. — 150. — pp.287-91.
Iaeeeaoeaiay iaaeoeia e ?aaaeeeoaoey, 1999, ¹ 4, no?. 13-17.
ÏÅÐÑÏÅÊÒÈÂÛ ËÅ×ÅÍÈß ÕÐÎÍÈ×ÅÑÊÎÉ
ÁÎËÈ Ó ÎÍÊÎËÎÃÈ×ÅÑÊÈÕ ÁÎËÜÍÛÕ
ÀÍÀËÜÃÅÒÈÊÀÌÈ ÏÐÎËÎÍÃÈÐÎÂÀÍÍÎÃÎ
ÄÅÉÑÒÂÈß
A.A. Iiaeeia, I.A. Aaeniai, A.I. I?ioi?ia, N.A. ?oaie
Iineianeee iao?ii-enneaaiaaoaeuneee einoeooo ei. I.A. Aa?oaia,
?IOIO ea?aiey o?iie?aneeo aieaauo neia?iiia o
iieieiae?aneeo aieuiuo,
Eaoaa?a iieieiaee n eo?nii iaeeeaoeaiie iiiiue OIII
IIA ei. E.I. Na?aiiaa, Iineaa
Ia i?ioy?aiee iiiaeo eao a ?innee e no?aiao NIA neeuii-
aaenoao?uea ia?eioe?aneea aiaeuaaoeee auee i?aanoaaeaiu a
aeaa eiuaeoeiiiuo eaea?noaaiiuo oi?i (i?iiaaie, iiiiiii,
ii?oeia aea?ioei?ea), ?oi cia?eoaeuii ia?aie?eaaei aicii?-
iinou i?iaaaaiey i?ioeaiaieaaie oa?aiee a niioaaonoaee n
i?eioeiaie, ?aeiiaiaiaaiiuie yenia?oaie Anaie?iie i?aa-
iecaoee ca?aaiio?aiaiey: eiaeaeaoaeuiay yooaeoeaiay aiaeu-
aaoe?aneay aica, iaeiaaceaiua i?ieiiae?iaaiiua eaea?noaai-
iua oi?iu, i?eiaiaiea i?aia?aoa «ii ?anai» e «ii ia?anoa?-
uae» neea aaenoaey. A aaiiie neooaoee iniaaiii i?iaeaiaoe?-
ii niae?aaiea yoeo i?eioeiia a aiaoeaoi?iuo e aiiaoieo on-
eiaeyo, oae eae yoi nii?y?aii n iaiaoiaeiinou? iiiaie?aoiuo
eiuaeoee ia?eioe?aneiai aiaeuaaoeea, ?oi o?aaoao aiaea?aiey a
yoio i?ioann iao?iia?iuo iaaeoeineeo nanoa? e auacaia a?e-
aaa nei?ie iaaeoeineie iiiiue. I?e yoii yoe oneeey ia iiaoo
aa?aioe?iaaou yooaeoeaiiai iaacaieeaaiey, nicaaaay no?anni-
ao? neooaoe? aie?oa iaoeaioa, io?aa?uaainy a iaeaa?aiee
no?aaaiee.
Iineaaiea aanyoeeaoey iciaiaiiaaiu ?aaie?oeiiiuie on-
iaoaie oa?iaeieiaia a iaeanoe nicaaiey iaeiaaceaiuo e i?i-
eiiae?iaaiiuo eaea?noaaiiuo oi?i iieieaiuo (o?aiae eiia,
o?aioiaei, aeaea?ieiaaei) e iieaoiuo (ii?oeia noeuoao, o?ai-
naa?iaeuiue oaioaiee), eioi?ua iicaiey?o eiio?iee?iaaou
aieu io 10-12 ai 72 ?.
Iaoaieci aaenoaey iiaiaiuo i?aia?aoia iniiaai ia no?iai
aice?iaaiiii auaaeaiee aeoeaiiai aauanoaa ec ?aoa?aiuo ne-
noai, ?oi iicaieyao ainoe?u aaaeaaoiiai iaacaieeaaiey a ia?e-
ia i?iaaaaiey i?ioeaiaieaaie oa?aiee aac ainoe?aiey ieei-
auo eiioaio?aoee iieieaiuo e iieaoiuo aiaeuaaoeeia a ieacia
e?iae e niioaaonoaaiii n iaiaa au?a?aiiuie i?iyaeaieyie
iiai?iuo naienoa. Aa?iui i?aeiouanoaii i?aia?aoia iiaiai
iieieaiey yaeyaony aa?eaaaeuiinou aice?iaie, iicaiey?uay
iiaia?aou aaaeaaoio? eiaeaeaoaeuio? aiaeuaaoe?aneo? aico
aey ea?aiai iaoeaioa.
Iaeiieaiiue iaie iiuo i?eiaiaiey yoeo i?aia?aoia o iae-
aieaa oy?aeie eaoaai?ee aieuiuo, ieioi iiaaa?ueony i?ioeai-
aieaaie oa?aiee n iiiiuu? o?aaeoeiiiuo eiuaeoeiiiuo oi?i
ia?eioe?aneeo aiaeuaaoeeia, iicaieyao noaeou i aunieie yooae-
oeaiinoe aaiiiai iiaoiaa, ?oi aaao aicii?iinou eiio?iee?i-
aaou aieu o iiaaaey?uaai aieuoeinoaa iaoeaioia (ai 87%).
I?ieiiae?iaaiiua oi?iu oaio?aeuiuo aiaeuaaoeeia iicai-
ey?o aaaeaaoii eiio?iee?iaaou aenoa?aeuio? e niiaoe?aneo?
aieu, a i?e ea?aiee iae?iiaoe?aneie aiee oaeaniia?acia eo
eiiaeiaoey n ?aaeiia?iuie iaoiaaie iaacaieeaaiey e i?eia-
iaiea ?yaa aau?aaioiuo n?aanoa iaoiaaiaoe?aneiai aaenoaey. A
?yaa neo?aaa aicii?ii i?eiaiaiea iai?ieiiae?iaaiiuo iiei-
eaiuo e iieaoiuo aiaeuaaoeeia n iiiiuu? ?acee?iuo oeiia ai-
caoi?ia, iicaiey?ueo iiaaa??eaaou iaiaoiaeio? eiioaio?a-
oe? aiaeuaaoeea, naiay ai ieieioia iianiinou ?acaeoey iiai-
?iuo yooaeoia. Iaiaei yooaeoeaiinou oaeiai iiaoiaa cia?e-
oaeuii ie?a a nayce n eiaaceaiinou? aaiiie iaoiaeee.
Oaeei ia?acii, i?ieiiae?iaaiiua iaoiau i?ioeaiaieaaie oa-
?aiee aie?iu ii i?aao caiyou ainoieiia ianoi a ea?aiee aiea-
auo neia?iiia iieieiae?aneiai aaiaca. Aiaa?aiea eo a iieieiae-
?aneo? i?aeoeeo iicaieeo yooaeoeaii i?eiaiyou eo a aiaoeaoi?-
iuo, aiiaoieo e noaoeiia?iuo oneiaeyo, ei?aiiui ia?acii ec-
iaiyy neooaoe?, eiaaa no?aaa?uee io aiee iaoeaio e ?eaiu aai
naiue yaey?ony «caei?ieeaie» nenoaiu ca?aaiio?aiaiey.
?inneeneay iao?ii-i?aeoe?aneay eiioa?aioey «Iaoieiae?aneay
aieu», Iiaineae?ne, 14-16 ieoya?y 1999, no?.148-149.
ÑÏÎÑÎÁ ËÅ×ÅÍÈß ÒÎØÍÎÒÛ È ÐÂÎÒÛ ÏÐÈ
ÂÛÑÎÊÎÈÍÒÅÍÑÈÂÍÎÉ ÕÈÌÈÎÒÅÐÀÏÈÈ
A.A. Aaaiia, N.A. ??ii?ia, A.E. Eoiiia
??ineaaneay ainoaa?noaaiiay iaaeoeineay aeaaaiey, ?IIA,
??ineaaeu, ?inney
Aicieeiiaaiea oioiiou e ?aiou i?e aunieieioaineaiie oe-
ieioa?aiee ceiea?anoaaiiuo iiooieae eiaao nei?iue iaoa-
ieci. Iaiin?aanoaaiiuie i?e?eiaie oioiiou e ?aiou yaey?o-
180
Àíòîëîãèÿ íàó÷íûõ ïóáëèêàöèé
